Vivimed Labs Limited has informed the Exchange regarding 'Certificate under Regulation 74(5) of SEBI (Depositories and Participants)Regulations, 2018 for the quarter and year ended 31st March, 2025'.
VIVIMEDLAB · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Vivimed Labs has submitted to the Exchange the certificate required under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018 for the quarter and financial year ending 31st March 2025. This certificate is typically issued by the company's Registrar and Share Transfer Agent (RTA) to confirm that all physical shares received for dematerialisation have been duly processed and credited to investors' demat accounts. The filing is a routine, mandatory compliance requirement applicable to all listed companies on a quarterly and annual basis. It does not involve any change in capital, shareholding pattern, or business operations. No specific financial numbers or operational data are disclosed in this announcement.
This is a standard procedural filing with no material impact on the company's financials, share price, or shareholder value. Investors can view it as a basic housekeeping compliance update.